117 related articles for article (PubMed ID: 2142792)
1. Body fluids and their distribution in experimental hypertension.
Kunes J; Zicha J; Jelínek J
Physiol Bohemoslov; 1990; 39(1):95-101. PubMed ID: 2142792
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent DOCA-salt hypertension in Brattleboro rats: the role of vasopressin.
Zicha J; Kunes J; Jelínek J
Physiol Bohemoslov; 1987; 36(1):33-42. PubMed ID: 2954169
[TBL] [Abstract][Full Text] [Related]
3. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension.
Zicha J; Kunes J; Lébl M; Pohlová I; Slaninová J; Jelínek J
Am J Physiol; 1989 Jan; 256(1 Pt 2):R138-45. PubMed ID: 2912206
[TBL] [Abstract][Full Text] [Related]
4. The influence of high salt intake and/or chronic blood volume expansion on renin-angiotensin system in Brattleboro rats.
Pohlová I; Zicha J
Acta Physiol Scand; 1992 Jun; 145(2):115-20. PubMed ID: 1636441
[TBL] [Abstract][Full Text] [Related]
5. Distribution of body fluids: local mechanisms guarding interstitial fluid volume.
Aukland K
J Physiol (Paris); 1984; 79(6):395-400. PubMed ID: 6399307
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin and water distribution in rats with DOCA-salt hypertension.
Kunes J; Nedvídek J; Zicha J
J Hypertens Suppl; 1989 Dec; 7(6):S204-5. PubMed ID: 2632718
[TBL] [Abstract][Full Text] [Related]
7. Body fluid distribution in the maintenance of DOCA-salt hypertension in rats.
Tajima Y; Ichikawa S; Sakamaki T; Matsuo H; Aizawa F; Kogure M; Yagi S; Murata K
Am J Physiol; 1983 May; 244(5):H695-700. PubMed ID: 6846557
[TBL] [Abstract][Full Text] [Related]
8. Body fluid alterations and organ hypertrophy in age-dependent salt hypertension of Dahl rats.
Dobesová Z; Kunes J; Zicha J
Physiol Res; 1995; 44(6):377-87. PubMed ID: 8798273
[TBL] [Abstract][Full Text] [Related]
9. Sodium pump activity in young and adult salt hypertensive Dahl rats.
Zicha J; Bysková E; Kunes J; Pohlová I; Jelínek J
Klin Wochenschr; 1987; 65 Suppl 8():76-81. PubMed ID: 2439746
[TBL] [Abstract][Full Text] [Related]
10. Renal interstitial hydrostatic pressure and sodium excretion in hypertension and pregnancy.
Khraibi AA
J Hypertens Suppl; 2002 Jun; 20(3):S21-7. PubMed ID: 12187911
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
[TBL] [Abstract][Full Text] [Related]
12. Methylprednisolone-induced hypertension in the rat: evidence against the role of plasma volume changes, vasopressin and renal prostaglandin E2.
Ramos-Frendo B; Eloy L; Grünfeld JP
J Hypertens; 1985 Oct; 3(5):461-7. PubMed ID: 3864857
[TBL] [Abstract][Full Text] [Related]
13. Effect of DOCA-salt on angiotensin dependency and surgical reversal of hypertension in two-kidney, one clip renal hypertensive rats.
Takata Y; Doyle AE
J Hypertens; 1983 Jun; 1(1):57-63. PubMed ID: 6397514
[TBL] [Abstract][Full Text] [Related]
14. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
[TBL] [Abstract][Full Text] [Related]
15. Volume sensitive hypertension and the digoxin-like factor. Reversal by a Fab directed against digoxin in DOCA-salt hypertensive rats.
Krep H; Price DA; Soszynski P; Tao QF; Graves SW; Hollenberg NK
Am J Hypertens; 1995 Sep; 8(9):921-7. PubMed ID: 8541008
[TBL] [Abstract][Full Text] [Related]
16. [Changes in body fluid spaces in hypertension patients treated with different diuretics].
Shkhvatsabaia IK; Musaev ZM; Nekrasova AA; Suvorov IuI
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):62-8. PubMed ID: 6732934
[TBL] [Abstract][Full Text] [Related]
17. Dependence of saline-induced natriuresis upon exposure of the kidney to the physical effects of extracellular fluid volume expansion.
Fitzgibbons JP; Gennari FJ; Garfinkel HB; Cortell S
J Clin Invest; 1974 Dec; 54(6):1428-36. PubMed ID: 4436441
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats.
Wang DS; Xie HH; Shen FM; Cai GJ; Su DF
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):545-52. PubMed ID: 16026514
[TBL] [Abstract][Full Text] [Related]
19. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
Matsumura Y; Fujita K; Miyazaki Y; Takaoka M; Morimoto S
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S456-8. PubMed ID: 8587444
[TBL] [Abstract][Full Text] [Related]
20. Effects of resibufogenin in experimental hypertension.
Danchuk S; Sukhanov S; Horvat D; Uddin MN; Puschett JB
Am J Nephrol; 2008; 28(1):8-13. PubMed ID: 17890853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
